Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive

Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01445080	Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia	completed	Phase 1 / Phase 2	70	National Cancer Institute (NCI)NIH	2	Feb 2, 2021	clinicaltrials
NCT01427881	Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies	completed	Phase 2	43	Fred Hutchinson Cancer CenterOTHER	1	May 19, 2017